Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib - Medicines Patent Pool

Generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis’ nilotinib – Medicines Patent Pool

Breaking | 4 generic manufacturers sign sublicence agreements with the Medicines Patent Pool to produce generic versions of Novartis,’ nilotinib for the treatment of chronic myeloid leukaemia.
The four generic manufacturers companies include:

  1. Eugia Pharma Specialities Ltd (INDIA)
  2. Hetero (INDIA)
  3. Dr. Reddy’s Laboratories (INDIA)
  4. PT. Brightgene Biomedical Indonesia (INDONESIA)

 

Source:

cancer chronic myeloid leukaemia generic health for all India Indonesia Medicines Patent Pool nilotinib Novartis OncoDaily Pharma